What Is the Price of Prevention?
New Evidence from a Field Experiment
ResearchPosted on rand.org 2013Published in: Journal of Health Economics, v. 32, no. 1, Jan. 2013, p. 207-218
Policies to increase preventive testing in developing countries should include subsidies towards treatment costs.
New Evidence from a Field Experiment
ResearchPosted on rand.org 2013Published in: Journal of Health Economics, v. 32, no. 1, Jan. 2013, p. 207-218
How does increasing access to treatment affect the demand for preventive testing? In this paper we present results from a field experiment in Nigeria in which we offered cervical cancer screening to women at randomly chosen prices. To test our hypothesis, we also offered women a lottery where the payoff was a subsidy towards the cost of cervical cancer treatment (conditional upon a diagnosis of cervical cancer). We find that women randomly selected to receive the conditional cancer treatment subsidy were about 4 percentage points more likely to take up screening than those in the control group. We also show that reducing the price of screening by 10 cents increased take-up by about 1 percentage point. These results offer compelling evidence that the optimal set of subsidies to increase take-up of preventive testing in developing countries, must include subsidies towards treatment costs (in addition to price subsidies).
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.